Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lucy S, Kilburn"'
Autor:
Elena Lopez-Knowles, Simone Detre, Margaret Hills, Eugene F. Schuster, Maggie C. U. Cheang, Holly Tovey, Lucy S. Kilburn, Judith M. Bliss, John Robertson, Elizabeth Mallon, Anthony Skene, Abigail Evans, Ian Smith, Mitch Dowsett
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-10 (2022)
Abstract Background In clinical practice, oestrogen receptor (ER) analysis is almost entirely by immunohistochemistry (IHC). ASCO/CAP recommends cut-offs of
Externí odkaz:
https://doaj.org/article/b69c05c893f24935a330283cbc7187d8
Autor:
Claire Snowdon, Sarah Kernaghan, Laura Moretti, Nicholas C. Turner, Alistair Ring, Katie Wilkinson, Sue Martin, Stephanie Foster, Lucy S. Kilburn, Judith M. Bliss
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Platform trial designs are used increasingly in cancer clinical research and are considered an efficient model for evaluating multiple compounds within a single disease or disease subtype. However, these trial designs can be chall
Externí odkaz:
https://doaj.org/article/95aec4e90bb041c8a063405e0216014f
Autor:
Belinda Kingston, Rosalind J. Cutts, Hannah Bye, Matthew Beaney, Giselle Walsh-Crestani, Sarah Hrebien, Claire Swift, Lucy S. Kilburn, Sarah Kernaghan, Laura Moretti, Katie Wilkinson, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Jorge S. Reis-Filho, Michael Hubank, Iris Faull, Kimberly C. Banks, Richard B. Lanman, Isaac Garcia-Murillas, Judith M. Bliss, Alistair Ring, Nicholas C. Turner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Circulating tumour DNA can provide useful information on disease burden. Here, the authors analysed circulating tumour DNA from 800 patients from a breast cancer clinical trial and investigate the subclonal nature of the disease, and identify DNA mut
Externí odkaz:
https://doaj.org/article/5f176e5d5bcb4792adb4ec1effb35966
Autor:
Belinda Kingston, Rosalind J. Cutts, Hannah Bye, Matthew Beaney, Giselle Walsh-Crestani, Sarah Hrebien, Claire Swift, Lucy S. Kilburn, Sarah Kernaghan, Laura Moretti, Katie Wilkinson, Andrew M. Wardley, Iain R. Macpherson, Richard D. Baird, Rebecca Roylance, Jorge S. Reis-Filho, Michael Hubank, Iris Faull, Kimberly C. Banks, Richard B. Lanman, Isaac Garcia-Murillas, Judith M. Bliss, Alistair Ring, Nicholas C. Turner
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/c4a8fb81f49749e99d11db28fb611c64
Autor:
Tom, Treasure, Loic, Lang-Lazdunski, David, Waller, Judith M, Bliss, Carol, Tan, James, Entwisle, Michael, Snee, Mary, O'Brien, Gill, Thomas, Suresh, Senan, Ken, O'Byrne, Lucy S, Kilburn, James, Spicer, David, Landau, John, Edwards, Gill, Coombes, Liz, Darlison, Julian, Peto, J, Edwards
Publikováno v:
The Lancet Oncology
Lancet Oncology, 12(8), 763-772. Lancet Publishing Group
Treasure, T, Lang-Lazdunski, L, Waller, D, Bliss, J M, Tan, C, Entwisle, J, Snee, M, O'Brien, M, Thomas, G, Senan, S, O'Byrne, K, Kilburn, L S, Spicer, J, Landau, D, Edwards, J, Coombes, G, Darlison, L & Peto, J 2011, ' Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study ', Lancet Oncology, vol. 12, no. 8, pp. 763-772 . https://doi.org/10.1016/S1470-2045(11)70149-8
Lancet Oncology, 12(8), 763-772. Lancet Publishing Group
Treasure, T, Lang-Lazdunski, L, Waller, D, Bliss, J M, Tan, C, Entwisle, J, Snee, M, O'Brien, M, Thomas, G, Senan, S, O'Byrne, K, Kilburn, L S, Spicer, J, Landau, D, Edwards, J, Coombes, G, Darlison, L & Peto, J 2011, ' Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study ', Lancet Oncology, vol. 12, no. 8, pp. 763-772 . https://doi.org/10.1016/S1470-2045(11)70149-8
Summary Background The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed in a randomised trial. We aimed to assess the clinical outco